Aimedis is now part of Digital Health Citizen

Aimedis is proud to annouce that it’s now part of the Digital Health Citizen project in Germany, which is starting in the area of Cologne and Bonn. The project aims for at first up to 10 Million German citizens to store and securely administrate their medical data and connect those citizens to medical services like online appointments, videochat with doctors, prescriptions and much more.

Aimedis platform Version 2 will contribute to this unique project and besides the exisiting cooperations with the known hospital groups, will establish its products on the German healthcare market.

Among other ehealth providers companies like IBM participate in the project but also university hospitals from the area and the Hasso Plattner Institute are now members of the Digital Health Citizen project.

Von |2019-12-10T16:08:32+01:00Dezember 10th, 2019|News|0 Kommentare

Cryptocurrencies including the Aimedis token (AIM) now accepted for payments

We’re glad to announce, that Aimedis now accepts cryptocurrencies including our Aimedis token (AIM) for payments of all medical services available on this site. For now we also accepted Bitcoin (BTC) and Ethereum (ETH).

Aimedis token holders profit in multiple ways when paying for the services using the AIM tokens. First we give a 10% discount on all services paid with the tokens, second we accept the AIM token at a price of 0,15 USD per token, while the initial price was 0,12 USD.

In case you pay your selected services using the AIM tokens please send them to the wallet address stated on the payments page and send us the transaction ID together with your invoice number to

Thus presale token buyers can already profit from their purchase before the tokens gets listed on cryptocurrency exchanges.

Von |2019-07-30T20:45:53+02:00Juli 30th, 2019|BREAKING NEWS, ICO, News|0 Kommentare

Aimedis engaging stronger in healthcare & industry consulting

Aimedis has actually started to enforce its consulting sector and offers healthcare, blockchain and IT consulting (with a focus on healthcare IT security) for a wider range of customers. Aimedis actual customers come from healthcare organizations like hospital groups, insurance companies, the pharmaceutical industry, governmental organizations and consulting firms.

For more information please contact us via or book an appointment via

to get to know, what Aimedis can do for you and how we can help you optimize your workflows.


Von |2019-07-09T21:20:22+02:00Juli 9th, 2019|News|0 Kommentare

Apps for QM and ICU now online in the stores

The native mobile apps for Aimedis QM and ICU can be downloaded now in the iOS App Store and the Google Play Store.

For QM you will need an account before you can start using it.

if you like to get a test account, please contact us via .

ICU is dedicated to medical professionals. For more information please visit .


Von |2019-07-04T16:46:30+02:00Juli 4th, 2019|News|0 Kommentare

Aimedis SecondOpinion is now Aimedis Elements

Aimedis SecondOpinion has been relaunched as Aimedis Elements as we combine easy accessible ehealth applications


  • Videochat
  • Second Opinion
  • eAppointment
  • ePrescription & eSickCertificate
  • ICU serviceportal
  • Aimedis QM & certification

in one and give doctors & patients the option to access these features outside of the Aimedis ecosystem.
Data from Aimedis Elements can be ported to the Aimedis ecosystem at any time.

Please contact us for further information.


Von |2019-04-20T11:31:51+02:00April 20th, 2019|News, Platform|0 Kommentare

Aimedis ICO Presale finished – Token to be sent to the presale participants in the next 2 weeks

Dear supporters, token buyers and friends. We are looking back at a very moving and intersting time in the crypto space in the last months. Aimedis thanks all of you who help Aimedis realize the vision of a unique medical ecosystem that will change the way people communicate and handle their health data and the way they communicate with their doctors and medical institutions.

Aimedis has finished the presale in November 2018 and has postponed the main sale of the Aimedis tokens until the market has recovered. The team has also discussed listing the token directly after the presale but we decided not to do that to protect all the people
who bought the token in the presale and the company as many examples showed a massive decrease in value for tokens listed in the bear market due to low market volumes.

So please stand by for Aimedis next steps, we will update you about the upcoming main sale and the listing process of AIM tokens on several exchanges.

All you tokens buyers that bought the token in the presale watch out for your wallets in the upcoming 2 weeks.

For any questions, concerns or ideas, please contact us any time via

We wish each and everyone of you a successful year 2019 in the crypto market and together with us.


Your Aimedis team

Von |2019-02-04T12:37:18+01:00Februar 3rd, 2019|News|0 Kommentare

Dementia – Developments In Care


New developments in Healthtech are happening all the time. Here is one which has hit the news headlines recently that really sounds very interesting.


Dementia Research

Researchers at a Japanese University have developed an AI system that can help to diagnose dementia.

The system that they have devised is able to detect the very early signs, much earlier than traditional methods. This means that patients can be made aware of potential problems very early on. Giving them more time to take  full advantage of treatment options, and so have a better long term outcome.


Currently, diagnosing dementia can be time consuming, expensive and distressing for patients. Traditional scans are used in conjunction with cognitive function tests, to check the function of the brain.

A global ageing population means that now more people are developing dementia, so there is a real need for quick, effective diagnosis that can lead to an earlier intervention.

New Developments

A group of researchers who are based at Osaka University and The NARA Institute of Science and Technology have discovered that it is indeed possible to detect the very early signs of dementia . And that  it is possible to do this with AI, quickly, effectively and in a non invasive manner. This helps patients save time, money and more importantly have a much less stressful experience.


This  technique uses machine learning in such a way that it is possible to study the way that elderly people speak when answering simple questions from a computer avatar.

The AI system is able to create a dialogue with elderly patients. It then records  their speech patterns, language, and faces. From this information it is then able to complete an evaluation from analyzing gaze, response times,  intonation, and language used.

After just six questions, the AI system was able to identify which patients in a control group did suffer from dementia, with a success rate of over 90%.


Future Potential

The senior research author Takashi Kudo said, “If this technology is further developed, it will become possible to know whether or not an elderly individual is in the early stages of dementia through conversations with computer avatars at home on a daily basis. It will encourage them to seek medical help, leading to early diagnosis.”


One of the main advantages here, is that not only is the success rate of the test already high, with a potential for early and accurate diagnosis,  it can be a test which is very easily conducted at home. There is no need to visit any medical center, or Doctors office. This convenience can only be a positive thing – often travelling  can be a factor in determining whether an elderly patient feels well or confident enough to undergo traditional methods of testing.


This is an excellent example of how advances in the health tech industry mean  that healthcare is now becoming much more accessible. And more importantly, here is a major improvement in diagnosis and treatments for a whole range of issues. Patient care with regards to dementia is one of these areas which can benefit hugely.


Von |2018-10-03T22:18:14+02:00Oktober 3rd, 2018|AI in news, News|0 Kommentare

Wearables – Friend or Foe?

Wearables – Friend or Foe??

Earlier this week, Apple launched the latest version of the Apple watch.

 This is one of the first mainstream devices available to the public that can carry out ECG tests. Obviously there is the ability to detect heart conditions such as arrhythmic beating and low heart rates.

This exciting development is a real indication of our need and demand for wearable devices such as this. The smart health watches have really increased in popularity over a very short space of time.

We are fast becoming a worldwide community for whom healthcare, and taking the responsibility for our own health is now the norm. The days where generations before us were reliant on the family doctor are becoming more distant, as we now plug into our devices and search for our health solutions online.


But Could There Be A Problem??

This all sounds extremely positive. However, the chair of the Royal College of Surgeons Commission on The Future of Surgery has warned us of potential problems with our technological age.


Richard Kerr believes that the influx of health information to patients does have the potential to create problems.

He warns that Doctors and Hospitals will see more patients who may be both “confused and scared” about health information that they have accessed.  Kerr states that “..the NHS will need to be ready to handle an influx of patients with potentially valid concerns about their risk of falling ill in the future.” – as reported in Engineering and Technology.


Essentially this will lead to the “worried well” to be concerned about potential medical issues. Issues that they may not experience for many years.  While prevention is both key and the best solution, we do need to draw a balance between unnecessarily worrying about future possibilities.


So this is essentially, where the technology side of the health industry, and the human side of the industry need to meet!  Wearable technology is a fantastic development in our health care.  We do need to be very careful as to how this technology is used or misused. And it is an issue that Aimedis takes very seriously.


There is always worry about the health industry becoming impersonal. An institution fueled by AI robots with no compassion or concern  for the people who use it.

But ask any medical student studying to become a doctor . Yes it’s factual and sometimes detached. But a lot of study time is spent on how to communicate with patients, how to care and truly make a patient feel at ease.


At the end of the day – we need to ensure there is a balance between the technology, and the human!

The technology is enhanced by the human touch.  Just as the doctors’ work and research is undoubtedly enhanced by the available technology.


It’s an amazing time to be in the healthtech industry, and a challenging time as well.

Von |2018-09-22T21:33:27+02:00September 22nd, 2018|General, News|0 Kommentare

Mr. Miguel Sánchez de Pedro is new advisory board member

Aimedis feels humbled to welcome Mr. Miguel Sánchez de Pedro in the Aimedis advisory board.

He is banking expert, Senior Partner and founder of OxValue Advisers SL, a management consulting firm, specialising in banking advisory services to financial intermediaries, small and medium enterprises and start-up ventures.

Miguel is a financial professional with a 50+yr banking expertise, and an international career as advisor to the World Bank, EBRD, IFC, IADB, the EU as well as government institutions and the private sector in over 20 developing countries. Advisory undertakings include privatisations, corporate restructuring, equity investments, financial due diligence, banking regulations, corporate finance, business valuations and hands-on institutional building.

Miguel holds a Degree in Business Administration and former Certified Chartered Accountant (1978 to 2012).

Von |2018-05-21T00:22:34+02:00Mai 21st, 2018|News|0 Kommentare